Hubei University


Beijing University Team Potent Convalescent Plasma-based Antibody Ready for Clinical Trials: Could Reduce COVID-19 Recovery Time

A Beijing University research team working “day and night” claims to have successfully tested a drug that could shorten the recovery time for patients infected with SARS-CoV-2, the virus behind the COVID-19 pandemic, hence offering a more near-term approach to...

Can Recombinant Human Interferon Alpha-1b Nasal Drops Protect Medical Staff from COVID-19?

Shanghai Jiao Tong University School of Medicine recently concluded an open label, prospective, non-randomized and interventional Phase III study investigating the preventive effect of recombinant human interferon alpha nasal drops on the infection rates of COVID-19...

Pin It on Pinterest